🇺🇸 FDA
Patent

US 12215349

Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same

granted A61KA61K40/10A61K40/11

Quick answer

US patent 12215349 (Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K40/10, A61K40/11, A61K40/32, A61K40/428